ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT)

SEC filing

ADAPTIVE BIOTECHNOLOGIES CORPORATION

ADPT · CIK 1478320

4 · Oct 8, 2026 · Chief Commercial Officer, MRD BOBULSKY SUSAN sold 6,444 shares at $30.00/share ($193.3K)

Chief Commercial Officer, MRD BOBULSKY SUSAN sold 6,444 shares at $30.00/share ($193.3K)

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

xslF345X06/form4.xmlSEC.gov

Graphics and non-inline formats (not embedded below).

4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESform4.xml
Open SEC.gov